Eurizon Capital SGR S.p.A. Buys New Stake in Axon Enterprise, Inc $AXON

Eurizon Capital SGR S.p.A. bought a new stake in Axon Enterprise, Inc (NASDAQ:AXON) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 23,090 shares of the biotechnology company’s stock, valued at approximately $13,116,000.

Other large investors have also recently bought and sold shares of the company. NEOS Investment Management LLC increased its holdings in Axon Enterprise by 82.7% in the third quarter. NEOS Investment Management LLC now owns 25,369 shares of the biotechnology company’s stock valued at $18,206,000 after buying an additional 11,482 shares during the last quarter. Legal & General Group Plc increased its holdings in Axon Enterprise by 1.3% in the fourth quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock valued at $242,241,000 after buying an additional 5,419 shares during the last quarter. Vanguard Group Inc. increased its holdings in Axon Enterprise by 4.2% in the third quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock valued at $6,684,217,000 after buying an additional 376,904 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in Axon Enterprise by 93.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 23,365 shares of the biotechnology company’s stock valued at $13,270,000 after buying an additional 11,262 shares during the last quarter. Finally, BIT Capital GmbH increased its holdings in Axon Enterprise by 75.6% in the third quarter. BIT Capital GmbH now owns 3,535 shares of the biotechnology company’s stock valued at $2,537,000 after buying an additional 1,522 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $448.72 on Monday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $885.91. The stock’s 50-day moving average is $407.53 and its two-hundred day moving average is $494.02. The firm has a market cap of $36.17 billion, a price-to-earnings ratio of 180.21, a PEG ratio of 8.16 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.91 million. During the same quarter last year, the company posted $1.47 earnings per share. The business’s revenue was up 33.7% on a year-over-year basis. Analysts predict that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently commented on AXON shares. Zacks Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 19th. Robert W. Baird set a $800.00 price objective on Axon Enterprise in a report on Wednesday, February 25th. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a report on Thursday, May 7th. Royal Bank Of Canada dropped their price objective on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a report on Wednesday, February 25th. Finally, Craig Hallum reaffirmed a “buy” rating and set a $820.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 25th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $712.75.

Insider Activity at Axon Enterprise

In related news, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $400.00, for a total value of $800,000.00. Following the completion of the sale, the insider owned 52,813 shares in the company, valued at $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jeri Williams sold 157 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the sale, the director owned 1,159 shares of the company’s stock, valued at approximately $567,910. The trade was a 11.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 2,355 shares of company stock worth $977,233 over the last 90 days. Company insiders own 4.20% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.